Bristol-Myers Third-Quarter Profit Fell on Costs (Update1) Bristol-Myers Squibb Co., which has lost US patent protection on eight of its drugs since 2000, said third-quarter earnings fell 16 percent as costs rose and sales of the Pravachol cholesterol treatment fell.